_id
691b14db3c536f8df2318b51
Ticker
EQS.PA
Name
Equasens S. A.
Exchange
PA
Address
5 Allée de Saint-Cloud, Villers-les-Nancy, France, 54600
Country
France
Sector
Healthcare
Industry
Health Information Services
Currency
EUR
Website
https://equasens.com
Description
Equasens Société anonyme provides healthcare IT solutions in Europe. The company publishes software and connected solutions for pharmacies, medical-social establishments, doctors, and medical auxiliaries. It also manufactures connected electronic devices and appliances for healthcare professionals and patients. In addition, the company financing solutions for rental properties for healthcare professionals and other tertiary sectors. It serves healthcare facilities and private healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-les-Nancy, France. Equasens Société anonyme operates as a subsidiary of Marque Verte Sante.
Last Close
44.85
Volume
1330
Current Price
44
Change
0.22296544035674787
Last Updated
2025-12-30T12:49:43.314Z
Image
https://logo.clearbit.com/equasens.com
Ipo Date
-
Market Cap
674158272
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.4
Strong Buy
2
Buy
3
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
116000000
Cost Of Revenue
93744000
Gross Profit
22224000
Operating Expenses
1081000
Operating Income
21143000
Interest Expense
502000
Pretax Income
22688000
Net Income
18100000
Eps
1.2041649737947755
Dividends Per Share
18789000
Shares Outstanding
15031400
Income Tax Expense
4557000
EBITDA
115800000
Operating Margin
18.226724137931036
Total Other Income Expense Net
1545000
Cash
18792000
Short Term Investments
62943000
Receivables
62132000
Inventories
11943000
Total Current Assets
162344000
Property Plant Equipment
28856000
Total Assets
410921000
Payables
17496000
Short Term Debt
20636000
Long Term Debt
-
Total Liabilities
171655000
Equity
229965000
Bs_currency_symbol
-
Depreciation
8527000
Change In Working Capital
19977000
Cash From Operations
45792000
Capital Expenditures
6133000
Cash From Investing
-11476000
Cash From Financing
-31457000
Net Change In Cash
2805000
Cf_currency_symbol
-
PE
18.7657
PB
2.8759644815515406
ROE
7.870762942186854
ROA
4.404739597148843
FCF
39659000
Fcf Percent
0.3418879310344828
Piotroski FScore
4
Health Score
76
Deep Value Investing Score
4.5
Defensive Investing Score
7
Dividend Investing Score
3.5
Economic Moat Investing Score
8
Garp Investing Score
4
Growth Investing Score
3.5
Momentum Investing Score
4
Net Net Investing Score
4
Quality Investing Score
7.5
Value Investing Score
6.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
116000000
Quarters > 0 > income Statement > cost Of Revenue
93744000
Quarters > 0 > income Statement > gross Profit
22224000
Quarters > 0 > income Statement > operating Expenses
1081000
Quarters > 0 > income Statement > operating Income
21143000
Quarters > 0 > income Statement > interest Expense
502000
Quarters > 0 > income Statement > pretax Income
22688000
Quarters > 0 > income Statement > net Income
18100000
Quarters > 0 > income Statement > eps
1.2041649737947755
Quarters > 0 > income Statement > dividends Per Share
18789000
Quarters > 0 > income Statement > shares Outstanding
15031163
Quarters > 0 > income Statement > income Tax Expense
4557000
Quarters > 0 > income Statement > EBITDA
115800000
Quarters > 0 > income Statement > operating Margin
18.226724137931036
Quarters > 0 > income Statement > total Other Income Expense Net
1545000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
18792000
Quarters > 0 > balance Sheet > short Term Investments
62943000
Quarters > 0 > balance Sheet > receivables
62132000
Quarters > 0 > balance Sheet > inventories
11943000
Quarters > 0 > balance Sheet > total Current Assets
162344000
Quarters > 0 > balance Sheet > property Plant Equipment
28856000
Quarters > 0 > balance Sheet > total Assets
410921000
Quarters > 0 > balance Sheet > payables
17496000
Quarters > 0 > balance Sheet > short Term Debt
20636000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
171655000
Quarters > 0 > balance Sheet > equity
229965000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
17260000
Quarters > 0 > cash Flow > depreciation
8527000
Quarters > 0 > cash Flow > change In Working Capital
19977000
Quarters > 0 > cash Flow > cash From Operations
45792000
Quarters > 0 > cash Flow > capital Expenditures
6133000
Quarters > 0 > cash Flow > cash From Investing
-11476000
Quarters > 0 > cash Flow > cash From Financing
-31457000
Quarters > 0 > cash Flow > net Change In Cash
2805000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
1.2041649737947755
Quarters > 0 > ratios > PB
2.8759644815515406
Quarters > 0 > ratios > ROE
7.870762942186854
Quarters > 0 > ratios > ROA
4.404739597148843
Quarters > 0 > ratios > FCF
39659000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.3418879310344828
Quarters > 0 > health Score
76
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
108813000
Quarters > 1 > income Statement > cost Of Revenue
90361000
Quarters > 1 > income Statement > gross Profit
18404000
Quarters > 1 > income Statement > operating Expenses
-6002000
Quarters > 1 > income Statement > operating Income
24406000
Quarters > 1 > income Statement > interest Expense
542000
Quarters > 1 > income Statement > pretax Income
25567000
Quarters > 1 > income Statement > net Income
19045000
Quarters > 1 > income Statement > eps
1.2670481005921097
Quarters > 1 > income Statement > dividends Per Share
18789000
Quarters > 1 > income Statement > shares Outstanding
15031000
Quarters > 1 > income Statement > income Tax Expense
5884000
Quarters > 1 > income Statement > EBITDA
-62155000
Quarters > 1 > income Statement > operating Margin
22.429305321974397
Quarters > 1 > income Statement > total Other Income Expense Net
1161000
Quarters > 1 > income Statement > currency_symbol
EUR
Quarters > 1 > balance Sheet > cash
15987000
Quarters > 1 > balance Sheet > short Term Investments
31437000
Quarters > 1 > balance Sheet > receivables
59333000
Quarters > 1 > balance Sheet > inventories
10327000
Quarters > 1 > balance Sheet > total Current Assets
122454000
Quarters > 1 > balance Sheet > property Plant Equipment
29912000
Quarters > 1 > balance Sheet > total Assets
398012000
Quarters > 1 > balance Sheet > payables
13904000
Quarters > 1 > balance Sheet > short Term Debt
18592000
Quarters > 1 > balance Sheet > long Term Debt
27844000
Quarters > 1 > balance Sheet > total Liabilities
157325000
Quarters > 1 > balance Sheet > equity
231506000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
19045000
Quarters > 1 > cash Flow > depreciation
7673000
Quarters > 1 > cash Flow > change In Working Capital
-22580000
Quarters > 1 > cash Flow > cash From Operations
7598000
Quarters > 1 > cash Flow > capital Expenditures
3626000
Quarters > 1 > cash Flow > cash From Investing
-8399000
Quarters > 1 > cash Flow > cash From Financing
-9464000
Quarters > 1 > cash Flow > net Change In Cash
-10221000
Quarters > 1 > cash Flow > currency_symbol
EUR
Quarters > 1 > ratios > PE
1.2670481005921097
Quarters > 1 > ratios > PB
2.8567898888149768
Quarters > 1 > ratios > ROE
8.226568641849456
Quarters > 1 > ratios > ROA
4.785031607087223
Quarters > 1 > ratios > FCF
3972000
Quarters > 1 > ratios > Piotroski FScore
3
Quarters > 1 > ratios > fcf Percent
0.036502991370516394
Quarters > 1 > health Score
59
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
107987000
Quarters > 2 > income Statement > cost Of Revenue
79257000
Quarters > 2 > income Statement > gross Profit
28730000
Quarters > 2 > income Statement > operating Expenses
8499000
Quarters > 2 > income Statement > operating Income
20749000
Quarters > 2 > income Statement > interest Expense
1116000
Quarters > 2 > income Statement > pretax Income
21715000
Quarters > 2 > income Statement > net Income
17186000
Quarters > 2 > income Statement > eps
1.143370367906327
Quarters > 2 > income Statement > dividends Per Share
18789000
Quarters > 2 > income Statement > shares Outstanding
15031000
Quarters > 2 > income Statement > income Tax Expense
3631000
Quarters > 2 > income Statement > EBITDA
29803000
Quarters > 2 > income Statement > operating Margin
19.21434987544797
Quarters > 2 > income Statement > total Other Income Expense Net
966000
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
26208000
Quarters > 2 > balance Sheet > short Term Investments
37125000
Quarters > 2 > balance Sheet > receivables
56253000
Quarters > 2 > balance Sheet > inventories
10982000
Quarters > 2 > balance Sheet > total Current Assets
137437000
Quarters > 2 > balance Sheet > property Plant Equipment
30415000
Quarters > 2 > balance Sheet > total Assets
404344000
Quarters > 2 > balance Sheet > payables
18446000
Quarters > 2 > balance Sheet > short Term Debt
22959000
Quarters > 2 > balance Sheet > long Term Debt
31775000
Quarters > 2 > balance Sheet > total Liabilities
183303000
Quarters > 2 > balance Sheet > equity
212647000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
17186000
Quarters > 2 > cash Flow > depreciation
7130000
Quarters > 2 > cash Flow > change In Working Capital
21035000
Quarters > 2 > cash Flow > cash From Operations
44948000
Quarters > 2 > cash Flow > capital Expenditures
6656000
Quarters > 2 > cash Flow > cash From Investing
-12381000
Quarters > 2 > cash Flow > cash From Financing
-24847000
Quarters > 2 > cash Flow > net Change In Cash
7776000
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
1.143370367906327
Quarters > 2 > ratios > PB
3.1101496846887096
Quarters > 2 > ratios > ROE
8.0819386118779
Quarters > 2 > ratios > ROA
4.250341293552025
Quarters > 2 > ratios > FCF
38292000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.3545982386768778
Quarters > 2 > health Score
71
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
53993500
Quarters > 3 > income Statement > cost Of Revenue
39628500
Quarters > 3 > income Statement > gross Profit
14365000
Quarters > 3 > income Statement > operating Expenses
4249500
Quarters > 3 > income Statement > operating Income
10115500
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
10857500
Quarters > 3 > income Statement > net Income
8593000
Quarters > 3 > income Statement > eps
0.5650000207116265
Quarters > 3 > income Statement > dividends Per Share
9394500
Quarters > 3 > income Statement > shares Outstanding
15208849
Quarters > 3 > income Statement > income Tax Expense
1815500
Quarters > 3 > income Statement > EBITDA
13737500
Quarters > 3 > income Statement > operating Margin
18.734662505671977
Quarters > 3 > income Statement > total Other Income Expense Net
742000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
26208000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
44430000
Quarters > 3 > balance Sheet > inventories
10982000
Quarters > 3 > balance Sheet > total Current Assets
137437000
Quarters > 3 > balance Sheet > property Plant Equipment
30415000
Quarters > 3 > balance Sheet > total Assets
404344000
Quarters > 3 > balance Sheet > payables
18446000
Quarters > 3 > balance Sheet > short Term Debt
19188000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
183303000
Quarters > 3 > balance Sheet > equity
212647000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
8593000
Quarters > 3 > cash Flow > depreciation
3622000
Quarters > 3 > cash Flow > change In Working Capital
10517500
Quarters > 3 > cash Flow > cash From Operations
22036500
Quarters > 3 > cash Flow > capital Expenditures
3328000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-13368500
Quarters > 3 > cash Flow > net Change In Cash
3890500
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
0.5650000207116265
Quarters > 3 > ratios > PB
3.1469494326277823
Quarters > 3 > ratios > ROE
4.04096930593895
Quarters > 3 > ratios > ROA
2.1251706467760125
Quarters > 3 > ratios > FCF
18708500
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.34649541148471574
Quarters > 3 > health Score
66
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
216800000
Annuals > 0 > income Statement > cost Of Revenue
169618000
Annuals > 0 > income Statement > gross Profit
47134000
Annuals > 0 > income Statement > operating Expenses
2497000
Annuals > 0 > income Statement > operating Income
44637000
Annuals > 0 > income Statement > interest Expense
1100000
Annuals > 0 > income Statement > pretax Income
47282000
Annuals > 0 > income Statement > net Income
36200000
Annuals > 0 > income Statement > eps
2.3856596810333466
Annuals > 0 > income Statement > dividends Per Share
18789000
Annuals > 0 > income Statement > shares Outstanding
15174000
Annuals > 0 > income Statement > income Tax Expense
9515000
Annuals > 0 > income Statement > EBITDA
62988000
Annuals > 0 > income Statement > operating Margin
20.589022140221402
Annuals > 0 > income Statement > total Other Income Expense Net
2645000
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
15987000
Annuals > 0 > balance Sheet > short Term Investments
24176000
Annuals > 0 > balance Sheet > receivables
59333000
Annuals > 0 > balance Sheet > inventories
10327000
Annuals > 0 > balance Sheet > total Current Assets
122454000
Annuals > 0 > balance Sheet > property Plant Equipment
29912000
Annuals > 0 > balance Sheet > total Assets
398012000
Annuals > 0 > balance Sheet > payables
13904000
Annuals > 0 > balance Sheet > short Term Debt
18592000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
157325000
Annuals > 0 > balance Sheet > equity
231506000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
36231000
Annuals > 0 > cash Flow > depreciation
14669000
Annuals > 0 > cash Flow > change In Working Capital
619000
Annuals > 0 > cash Flow > cash From Operations
47554000
Annuals > 0 > cash Flow > capital Expenditures
11645000
Annuals > 0 > cash Flow > cash From Investing
-13898000
Annuals > 0 > cash Flow > cash From Financing
-36201000
Annuals > 0 > cash Flow > net Change In Cash
-2445000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
2.3856596810333466
Annuals > 0 > ratios > PB
2.956067661313314
Annuals > 0 > ratios > ROE
15.636743756101353
Annuals > 0 > ratios > ROA
9.095203159703727
Annuals > 0 > ratios > FCF
35909000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.16563191881918818
Annuals > 0 > health Score
83
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
219788000
Annuals > 1 > income Statement > cost Of Revenue
149910000
Annuals > 1 > income Statement > gross Profit
69878000
Annuals > 1 > income Statement > operating Expenses
14670000
Annuals > 1 > income Statement > operating Income
55208000
Annuals > 1 > income Statement > interest Expense
669000
Annuals > 1 > income Statement > pretax Income
58584000
Annuals > 1 > income Statement > net Income
47047000
Annuals > 1 > income Statement > eps
3.1004753157101317
Annuals > 1 > income Statement > dividends Per Share
17289000
Annuals > 1 > income Statement > shares Outstanding
15174125
Annuals > 1 > income Statement > income Tax Expense
9702000
Annuals > 1 > income Statement > EBITDA
71299000
Annuals > 1 > income Statement > operating Margin
25.11875079622181
Annuals > 1 > income Statement > total Other Income Expense Net
3376000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
18432000
Annuals > 1 > balance Sheet > short Term Investments
36253000
Annuals > 1 > balance Sheet > receivables
62022000
Annuals > 1 > balance Sheet > inventories
10314000
Annuals > 1 > balance Sheet > total Current Assets
132250000
Annuals > 1 > balance Sheet > property Plant Equipment
32863000
Annuals > 1 > balance Sheet > total Assets
394045000
Annuals > 1 > balance Sheet > payables
16093000
Annuals > 1 > balance Sheet > short Term Debt
22345000
Annuals > 1 > balance Sheet > long Term Debt
39323000
Annuals > 1 > balance Sheet > total Liabilities
166419000
Annuals > 1 > balance Sheet > equity
219277000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
47047000
Annuals > 1 > cash Flow > depreciation
13222000
Annuals > 1 > cash Flow > change In Working Capital
-3918000
Annuals > 1 > cash Flow > cash From Operations
61590000
Annuals > 1 > cash Flow > capital Expenditures
18417000
Annuals > 1 > cash Flow > cash From Investing
-50532000
Annuals > 1 > cash Flow > cash From Financing
-16087000
Annuals > 1 > cash Flow > net Change In Cash
-5004000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
3.1004753157101317
Annuals > 1 > ratios > PB
3.1209522088499937
Annuals > 1 > ratios > ROE
21.455510609867883
Annuals > 1 > ratios > ROA
11.939499295765712
Annuals > 1 > ratios > FCF
43173000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.19643019637104847
Annuals > 1 > health Score
85
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
214075000
Annuals > 2 > income Statement > cost Of Revenue
68553000
Annuals > 2 > income Statement > gross Profit
145522000
Annuals > 2 > income Statement > operating Expenses
89761000
Annuals > 2 > income Statement > operating Income
55213000
Annuals > 2 > income Statement > interest Expense
679000
Annuals > 2 > income Statement > pretax Income
54752000
Annuals > 2 > income Statement > net Income
46376000
Annuals > 2 > income Statement > eps
3.0562553030240625
Annuals > 2 > income Statement > dividends Per Share
15757000
Annuals > 2 > income Statement > shares Outstanding
15174125
Annuals > 2 > income Statement > income Tax Expense
6179000
Annuals > 2 > income Statement > EBITDA
67364000
Annuals > 2 > income Statement > operating Margin
25.79142823776714
Annuals > 2 > income Statement > total Other Income Expense Net
-461000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
23436000
Annuals > 2 > balance Sheet > short Term Investments
44576000
Annuals > 2 > balance Sheet > receivables
59850000
Annuals > 2 > balance Sheet > inventories
9311000
Annuals > 2 > balance Sheet > total Current Assets
137173000
Annuals > 2 > balance Sheet > property Plant Equipment
26610000
Annuals > 2 > balance Sheet > total Assets
350812000
Annuals > 2 > balance Sheet > payables
16810000
Annuals > 2 > balance Sheet > short Term Debt
18083000
Annuals > 2 > balance Sheet > long Term Debt
41232000
Annuals > 2 > balance Sheet > total Liabilities
154015000
Annuals > 2 > balance Sheet > equity
189776000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
55213000
Annuals > 2 > cash Flow > depreciation
13953000
Annuals > 2 > cash Flow > change In Working Capital
-5625000
Annuals > 2 > cash Flow > cash From Operations
56977000
Annuals > 2 > cash Flow > capital Expenditures
10226000
Annuals > 2 > cash Flow > cash From Investing
-18342000
Annuals > 2 > cash Flow > cash From Financing
-38272000
Annuals > 2 > cash Flow > net Change In Cash
-11376000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
3.0562553030240625
Annuals > 2 > ratios > PB
3.6061095054169128
Annuals > 2 > ratios > ROE
24.437231262119553
Annuals > 2 > ratios > ROA
13.219616204690832
Annuals > 2 > ratios > FCF
46751000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.21838607964498424
Annuals > 2 > health Score
85
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
193069000
Annuals > 3 > income Statement > cost Of Revenue
59253000
Annuals > 3 > income Statement > gross Profit
133816000
Annuals > 3 > income Statement > operating Expenses
83550000
Annuals > 3 > income Statement > operating Income
50265000
Annuals > 3 > income Statement > interest Expense
589000
Annuals > 3 > income Statement > pretax Income
51851000
Annuals > 3 > income Statement > net Income
39119000
Annuals > 3 > income Statement > eps
2.57800696910036
Annuals > 3 > income Statement > dividends Per Share
14269000
Annuals > 3 > income Statement > shares Outstanding
15174125
Annuals > 3 > income Statement > income Tax Expense
10621000
Annuals > 3 > income Statement > EBITDA
63767000
Annuals > 3 > income Statement > operating Margin
26.03473369624331
Annuals > 3 > income Statement > total Other Income Expense Net
1506000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
34812000
Annuals > 3 > balance Sheet > short Term Investments
29982000
Annuals > 3 > balance Sheet > receivables
48586000
Annuals > 3 > balance Sheet > inventories
8874000
Annuals > 3 > balance Sheet > total Current Assets
122254000
Annuals > 3 > balance Sheet > property Plant Equipment
27662000
Annuals > 3 > balance Sheet > total Assets
329950000
Annuals > 3 > balance Sheet > payables
14141000
Annuals > 3 > balance Sheet > short Term Debt
20676000
Annuals > 3 > balance Sheet > long Term Debt
51813000
Annuals > 3 > balance Sheet > total Liabilities
164715000
Annuals > 3 > balance Sheet > equity
159005000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
50265000
Annuals > 3 > cash Flow > depreciation
11911000
Annuals > 3 > cash Flow > change In Working Capital
-2488000
Annuals > 3 > cash Flow > cash From Operations
47516000
Annuals > 3 > cash Flow > capital Expenditures
10422000
Annuals > 3 > cash Flow > cash From Investing
-36193000
Annuals > 3 > cash Flow > cash From Financing
-9797000
Annuals > 3 > cash Flow > net Change In Cash
1182000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
2.57800696910036
Annuals > 3 > ratios > PB
4.303971809062609
Annuals > 3 > ratios > ROE
24.60237099462281
Annuals > 3 > ratios > ROA
11.856038793756628
Annuals > 3 > ratios > FCF
37094000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.19212820287047636
Annuals > 3 > health Score
79
Valuation > metrics > PE
18.7657
Valuation > metrics > PB
2.8759644815515406
Valuation > final Score
100
Valuation > verdict
Fair
Profitability > metrics > ROE
7.870762942186854
Profitability > metrics > ROA
11.149164736608682
Profitability > metrics > Net Margin
0.1560344827586207
Profitability > final Score
69
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
0.7464396756028091
Risk > metrics > Interest Coverage
42.11752988047809
Risk > final Score
88
Risk > verdict
Low
Liquidity > metrics > Current Ratio
4.257421588167419
Liquidity > metrics > Quick Ratio
3.9442200776250917
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
100
Prev Valuations > 1
68.8985031531129
Prev Valuations > 2
68.53050567372217
Prev Profitabilities > 0
73
Prev Profitabilities > 1
70
Prev Profitabilities > 2
51
Prev Risks > 0
88
Prev Risks > 1
88
Prev Risks > 2
62
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:09:48.672Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-30
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Equasens Société anonyme provides healthcare IT solutions in Europe. The company publishes software and connected solutions for pharmacies, medical-social establishments, doctors, and medical auxiliaries. It also manufactures connected electronic devices and appliances for healthcare professionals and patients. In addition, the company financing solutions for rental properties for healthcare professionals and other tertiary sectors. It serves healthcare facilities and private healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-les-Nancy, France. Equasens Société anonyme operates as a subsidiary of Marque Verte Sante.
Stock Price
€0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAquis Stock Exchange: Updated Application for Admission Announcement TradingView — Track All Markets
Read more →SAF-HOLLAND SE: Release of a capital market information TradingView — Track All Markets
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
2
Buy
3
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Equasens S. A.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.